Peter Varunok

1.5k total citations · 1 hit paper
4 papers, 557 citations indexed

About

Peter Varunok is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Peter Varunok has authored 4 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hepatology, 3 papers in Epidemiology and 1 paper in Infectious Diseases. Recurrent topics in Peter Varunok's work include Hepatitis C virus research (4 papers), Hepatitis B Virus Studies (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Peter Varunok is often cited by papers focused on Hepatitis C virus research (4 papers), Hepatitis B Virus Studies (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Peter Varunok collaborates with scholars based in United States, France and Romania. Peter Varunok's co-authors include Edward Tam, Stefan Zeuzem, Mark Sulkowski, Tolga Baykal, Rui Tato Marinho, Thomas Podsadecki, Adrian M. Di Bisceglie, Marc Bourlière, Tarek Hassanein and Junyuan Xiong and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Journal of Hepatology.

In The Last Decade

Peter Varunok

4 papers receiving 548 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin

2014 395 citations Stefan Zeuzem, Ira M. Jacobson et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Varunok United States	4	537	484	149	37	17	4	557
Mark S. Sulkowski United States	7	383 0.7×	344 0.7×	81 0.5×	21 0.6×	15 0.9×	14	432
Isabelle Lonjon‐Domanec France	14	541 1.0×	522 1.1×	79 0.5×	48 1.3×	35 2.1×	37	596
Eirum Chaudhri Japan	3	509 0.9×	437 0.9×	113 0.8×	60 1.6×	26 1.5×	3	531
D. Hueppe Germany	14	623 1.2×	562 1.2×	144 1.0×	61 1.6×	26 1.5×	47	673
Deborah D. Brown United States	4	376 0.7×	334 0.7×	177 1.2×	25 0.7×	14 0.8×	5	450
Bart Fevery United States	15	928 1.7×	849 1.8×	317 2.1×	74 2.0×	31 1.8×	35	949
V. V. Rafalsky Russia	6	327 0.6×	342 0.7×	91 0.6×	40 1.1×	19 1.1×	13	418
Zayani Sims United States	7	373 0.7×	332 0.7×	69 0.5×	47 1.3×	24 1.4×	10	401
Tolga Baykal United States	3	406 0.8×	369 0.8×	113 0.8×	25 0.7×	16 0.9×	5	418
S Mauss Germany	7	245 0.5×	216 0.4×	60 0.4×	30 0.8×	30 1.8×	17	300

Countries citing papers authored by Peter Varunok

Since Specialization

Citations

This map shows the geographic impact of Peter Varunok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Varunok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Varunok more than expected).

Fields of papers citing papers by Peter Varunok

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Varunok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Varunok. The network helps show where Peter Varunok may publish in the future.

Co-authorship network of co-authors of Peter Varunok

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Varunok. A scholar is included among the top collaborators of Peter Varunok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Varunok. Peter Varunok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Lalezari, Jacob, Peter Varunok, Kris V. Kowdley, et al.. (2015). Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine. Journal of Hepatology. 63(2). 364–369. 88 indexed citations

2.

Lawitz, Eric, Mihály Makara, Ulus Salih Akarca, et al.. (2015). Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis. Gastroenterology. 149(4). 971–980.e1. 68 indexed citations

3.

Zeuzem, Stefan, Ira M. Jacobson, Tolga Baykal, et al.. (2014). Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin. New England Journal of Medicine. 370(17). 1604–1614. 395 indexed citations breakdown →

4.

Varunok, Peter, et al.. (2011). Evaluation of pharmacokinetics, user handling, and tolerability of peginterferon alfa-2a (40 kDa) delivered via a disposable autoinjector device. Patient Preference and Adherence. 5. 587–587. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact